Clinical Trials
9
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Long-term Extension of Study GNC-401
- Conditions
- Multiple Sclerosis
- Interventions
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2022-07-07
- Lead Sponsor
- GeNeuro Innovation SAS
- Target Recruit Count
- 33
- Registration Number
- NCT05049161
- Locations
- 🇸🇪
Center for Neurology, Academic Specialist Center, Stockholm, Sweden
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- GeNeuro Innovation SAS
- Target Recruit Count
- 41
- Registration Number
- NCT04480307
- Locations
- 🇸🇪
Center for Neurology, Academic Specialist Center, Stockholm, Sweden
Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers
- First Posted Date
- 2015-05-25
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- GeNeuro Innovation SAS
- Target Recruit Count
- 21
- Registration Number
- NCT02452996
- Locations
- 🇩🇪
PAREXEL Early Phase Clinical Unit, Berlin, Germany
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- GeNeuro Innovation SAS
- Target Recruit Count
- 25
- Registration Number
- NCT01804660
- Locations
- 🇫🇷
Etablissement Français du Sang Rhône Alpes - 1 route de Taninges, Annemasse, France
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
- Conditions
- Multiple Sclerosis (MS)Relapsing-Remitting MSPrimary Progressive MSSecondary Progressive MSClinically Isolated Syndrome (CIS)
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- GeNeuro Innovation SAS
- Target Recruit Count
- 58
- Registration Number
- NCT01804647
- Locations
- 🇫🇷
Hospices civils de Lyon - Service de Neurologie A - 59 Boulevard Pinel, Bron cedex, France
🇫🇷CHU Timone - Service de Neurologie et CRMBM CNRS 7339 - 264, rue Saint Pierre, Marseille Cedex 5, France
🇪🇸Hospital Universitari and Research Institute Vall d'Hebron - Servicio de Neuroimunologia de Nuestro Centro - Pg. Vall d'Hebron 119-129, Barcelona, Cataluna, Spain
- Prev
- 1
- 2
- Next